These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1882005)

  • 1. Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen.
    File SE; Mabbutt PS; Andrews N
    Psychopharmacology (Berl); 1991; 104(1):62-6. PubMed ID: 1882005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat.
    File SE; Zharkovsky A; Gulati K
    Neuropharmacology; 1991 Feb; 30(2):183-90. PubMed ID: 2030822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the median raphé nucleus--dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety.
    Andrews N; File SE; Fernandes C; Gonzalez LE; Barnes NM
    Psychopharmacology (Berl); 1997 Apr; 130(3):228-34. PubMed ID: 9151356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal.
    File SE; Zharkovsky A; Hitchcott PK
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):87-93. PubMed ID: 1557510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raised [3H]-5-HT release and 45Ca2+ uptake in diazepam withdrawal: inhibition by baclofen.
    Andrews N; Zharkovsky A; File SE
    Pharmacol Biochem Behav; 1992 Apr; 41(4):695-9. PubMed ID: 1594636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal.
    Knapp DJ; Overstreet DH; Breese GR
    Alcohol Clin Exp Res; 2007 Apr; 31(4):582-95. PubMed ID: 17374037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal.
    File SE; Andrews N
    Psychopharmacology (Berl); 1991; 105(4):578-82. PubMed ID: 1771225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence.
    Andrews N; File SE
    Psychopharmacology (Berl); 1993; 112(1):21-5. PubMed ID: 7871006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?
    Andrews N; File SE
    Psychopharmacology (Berl); 1992; 108(3):333-7. PubMed ID: 1523283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.
    Chopin P; Assié MB; Briley M
    Psychopharmacology (Berl); 1993; 110(1-2):19-26. PubMed ID: 7870883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.
    File SE
    Pharmacol Biochem Behav; 1997 Nov; 58(3):747-52. PubMed ID: 9329068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.
    File SE; Andrews N
    Eur J Pharmacol; 1993 Jun; 237(1):127-30. PubMed ID: 8102974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam.
    Fernandes C; Arnot MI; Irvine EE; Bateson AN; Martin IL; File SE
    Psychopharmacology (Berl); 1999 Aug; 145(3):251-9. PubMed ID: 10494573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety.
    Baldwin HA; File SE
    Psychopharmacology (Berl); 1989; 97(3):424-6. PubMed ID: 2497494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent treatment with verapamil prevents diazepam withdrawal-induced anxiety, in the absence of altered calcium flux in cortical synaptosomes.
    Hitchcott PK; Zharkovsky A; File SE
    Neuropharmacology; 1992 Jan; 31(1):55-60. PubMed ID: 1542403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand.
    Kita A; Kinoshita T; Kohayakawa H; Furukawa K; Akaike A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1040-5. PubMed ID: 19497344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.
    Harro J; Põld M; Vasar E
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):62-7. PubMed ID: 2314484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine withdrawal: behavioural pharmacology and neurochemical changes.
    File SE; Andrews N
    Biochem Soc Symp; 1993; 59():97-106. PubMed ID: 7910743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of GABAB ligands on alcohol withdrawal in mice.
    Humeniuk RE; White JM; Ong J
    Pharmacol Biochem Behav; 1994 Nov; 49(3):561-6. PubMed ID: 7862708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of two chronic diazepam treatment regimes on withdrawal anxiety and AMPA receptor characteristics.
    Allison C; Pratt JA
    Neuropsychopharmacology; 2006 Mar; 31(3):602-19. PubMed ID: 15970947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.